RD

Rajendra Deepchand Bedmutha

Active Director Director DIN 00400859
DIN 00400859 First appointment Apr 1995 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 3 historical roles
Total affiliations 5 Since Apr 1995
Shareholding value •••• Premium profile

About Rajendra Deepchand Bedmutha

Data last updated:

Rajendra Deepchand Bedmutha is a Director at Ashoka Institute Of Medical Sciences & Research (since 2022) and Additional Director at Chaitanya Nursing Home Private Limited (since 2022). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹10.21 Cr; the largest is Ashoka Institute Of Medical Sciences & Research at ₹9.14 Cr (FY 2024). Earlier, Rajendra Deepchand Bedmutha was a Director at Shree Saibaba Heart Institute And Research Centre Private Limited (2009–2016) and Director at Nidaan Sonography Centre Private Limited (from 1995) and 1 more.

DIN 00400859
Primary Designation Director
Industry Healthcare
First Appointment 10 Apr 1995
Oldest Company Age 31 yrs
Largest company Ashoka Institute Of Medical Sciences & Research · ₹9.14 Cr (FY 2024)
Combined revenue ₹10.21 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Sep 20222014₹9.14 Cr (FY 2024)Active
Additional Director01 Oct 20221995₹1.07 Cr (FY 2021)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Aug 20092007₹17.26 Cr (FY 2016)Converted To Llp
Director10 Apr 19951995₹26.5 Lakh (FY 2016)Strike Off
Director02 Aug 20022002Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Chaitanya Nursing Home Private Limited
Nidaan Sonography Centre Private Limited
Ankur Fertility And Endoscopy Centre Private Limited
Ashoka Institute Of Medical Sciences & Research
Premium access

Shareholding and investment profile for Rajendra Deepchand Bedmutha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajendra Deepchand Bedmutha

Rajendra Deepchand Bedmutha currently holds 2 directorships: Ashoka Institute Of Medical Sciences & Research (Director, since 15 Sep 2022, revenue ₹9.14 Cr (FY 2024)); Chaitanya Nursing Home Private Limited (Additional Director, since 01 Oct 2022, revenue ₹1.07 Cr (FY 2021)).

Rajendra Deepchand Bedmutha was first appointed on 10 Apr 1995 as Director at Nidaan Sonography Centre Private Limited. The most recent appointment on record is 01 Oct 2022 at Chaitanya Nursing Home Private Limited.

The 2 current companies of Rajendra Deepchand Bedmutha that report revenue have a combined latest revenue of ₹10.21 Cr: Ashoka Institute Of Medical Sciences & Research ₹9.14 Cr (FY 2024); Chaitanya Nursing Home Private Limited ₹1.07 Cr (FY 2021).

Rajendra Deepchand Bedmutha held 3 earlier board appointments: Shree Saibaba Heart Institute And Research Centre Private Limited (Director, 01 Aug 2009 to 15 Oct 2016); Nidaan Sonography Centre Private Limited (Director, from 10 Apr 1995); Ankur Fertility And Endoscopy Centre Private Limited (Director, from 02 Aug 2002).

The current boards of Rajendra Deepchand Bedmutha's companies include Astha Ashish Kataria (Ashoka Institute Of Medical Sciences & Research), Sushil Ramanlal Parakh (Ashoka Institute Of Medical Sciences & Research), Ramnath Baburao Darade (Chaitanya Nursing Home Private Limited), Shailaja Rajendra Bedmutha (Chaitanya Nursing Home Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available